These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 8764101

  • 1. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM.
    Cancer Res; 1996 Jul 15; 56(14):3173-9. PubMed ID: 8764101
    [Abstract] [Full Text] [Related]

  • 2. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.
    Cancer Res; 1997 Nov 01; 57(21):4692-8. PubMed ID: 9354423
    [Abstract] [Full Text] [Related]

  • 3. The Fragile Histidine Triad gene and breast cancer.
    Yang Q, Yoshimura G, Sakurai T, Kakudo K.
    Med Sci Monit; 2002 Jul 01; 8(7):RA140-4. PubMed ID: 12118213
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 5. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 6. Study of FHIT transcripts in normal and malignant breast tissue.
    Bièche I, Latil A, Becette V, Lidereau R.
    Genes Chromosomes Cancer; 1998 Dec 01; 23(4):292-9. PubMed ID: 9824201
    [Abstract] [Full Text] [Related]

  • 7. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT.
    Cancer Res; 1998 May 01; 58(9):1804-7. PubMed ID: 9581816
    [Abstract] [Full Text] [Related]

  • 8. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D.
    Mol Cancer Res; 2006 Feb 01; 4(2):93-9. PubMed ID: 16513840
    [Abstract] [Full Text] [Related]

  • 9. Abnormal transcripts of FHIT gene in thyroid cancer.
    Chang TJ, Tsai TC, Wu YL, Yang HM, Chi CW, Yang AH, Lee CH.
    Oncol Rep; 1998 Feb 01; 5(1):245-7. PubMed ID: 9458330
    [Abstract] [Full Text] [Related]

  • 10. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC.
    Cancer Res; 2000 Feb 15; 60(4):1049-53. PubMed ID: 10706123
    [Abstract] [Full Text] [Related]

  • 11. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
    Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T, Takahashi T.
    Cancer Res; 1996 Dec 15; 56(24):5579-82. PubMed ID: 8971157
    [Abstract] [Full Text] [Related]

  • 12. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
    Hendricks DT, Taylor R, Reed M, Birrer MJ.
    Cancer Res; 1997 Jun 01; 57(11):2112-5. PubMed ID: 9187105
    [Abstract] [Full Text] [Related]

  • 13. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH, Kim WH, Kim HK, Woo KM, Nam HS, Kim HS, Kim JG, Cho MH.
    Biochem Biophys Res Commun; 2001 Jun 15; 284(3):850-5. PubMed ID: 11396980
    [Abstract] [Full Text] [Related]

  • 14. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT, Lei J, Shi YQ, Yin J, Wang S, Souza RF, Kong D, Shimada Y, Smolinski KN, Greenwald BD, Abraham JM, Harpaz N, Meltzer SJ.
    Oncogene; 1997 Jul 03; 15(1):101-5. PubMed ID: 9233782
    [Abstract] [Full Text] [Related]

  • 15. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Shimizu Y, Mori I, Sakurai T, Kakudo K.
    Clin Cancer Res; 2002 Sep 03; 8(9):2890-3. PubMed ID: 12231533
    [Abstract] [Full Text] [Related]

  • 16. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX, Huang XP, Zhao CX, Xu X, Han YL, Cai Y, Wu RL, Wu M, Zhan QM, Wang MR.
    Ai Zheng; 2004 Sep 03; 23(9):992-8. PubMed ID: 15363189
    [Abstract] [Full Text] [Related]

  • 17. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T, Sasagawa T, Yamazaki H, Sakaike J, Ishikawa H, Inoue M.
    Cancer; 1999 May 01; 85(9):2001-10. PubMed ID: 10223242
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Genes Chromosomes Cancer; 1997 Sep 01; 20(1):98-102. PubMed ID: 9290961
    [Abstract] [Full Text] [Related]

  • 19. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
    Michael D, Beer DG, Wilke CW, Miller DE, Glover TW.
    Oncogene; 1997 Oct 02; 15(14):1653-9. PubMed ID: 9349498
    [Abstract] [Full Text] [Related]

  • 20. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.
    Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce CM.
    Cancer Res; 1999 Aug 15; 59(16):3866-9. PubMed ID: 10463571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.